Novel control of Dengue fever

August 24, 2011

The spread of Dengue fever in northern Australia may be controlled by a bacterium that infects mosquitoes that harbor the virus, Australian and U.S. researchers report Aug. 25 in two papers published in the journal Nature.

The result grew out of work more than 20 years ago by population biologist Michael Turelli, professor of evolution and ecology at UC Davis, and Ary Hoffmann, now at the University of Melbourne, Australia, who are among the coauthors of one of the new Nature papers.

Turelli and Nick Barton of the Institute of Science and Technology, Austria, also describe the mathematical basis of the elimination project in a paper to be published in the journal in September.

Dengue fever is caused by four spread by the mosquito . The disease causes and has been called "breakbone fever" because of the joint aches and muscle pains it causes. Dengue viruses can also cause a potentially fatal disease, dengue hemorrhagic fever, in people who have previously been infected with a different strain of the virus.

Dengue viruses are found throughout the tropics and and appear annually in . The researchers released infected with the bacterial parasite Wolbachia, which suppresses the virus, and now report that the Wolbachia parasite spreads rapidly through the wild mosquito population.

"The results show we can completely transform local populations in a few months," Turelli said.

Wolbachia is transmitted by to their offspring. A pair of infected mosquitoes produce slightly fewer eggs than an uninfected couple, but when an infected male mosquito mates with an uninfected female, she produces no eggs at all. That provides a big reproductive advantage to the spread of Wolbachia-infected mosquitoes, generation by generation.

"It's natural selection on steroids," Turelli said.

It turns out that Wolbachia also suppresses various other microbes living in the same mosquito – including the dengue virus. As these virus-resistant mosquitoes spread through the wild population, dengue transmission should dry up.

Turelli and Hoffmann first described what turned out to be Wolbachia spreading among Drosophila flies in California's Central Valley in 1991, and Barton developed much of the relevant mathematics in the late 1970s while trying to understand the genetics of grasshoppers in the French Alps. That basic research by Turelli, Hoffman and Barton provides the biological and mathematical basis for the dengue control strategy.

"At the time, none of us expected that this original research might contribute to human health. This is very exciting, once-in-a-lifetime opportunity," Turelli said. "We never thought this would turn into an eradication project."

The mathematics is complicated because when Wolbachia is rare, its spread through an insect population is disadvantaged because infected couples lay fewer eggs than uninfected. However, once the frequency of the infection crosses a certain threshold, there is a strong advantage to its spread.

Originally, Turelli and other researchers lead by Scott O'Neill at the University of Queensland, funded by the Bill & Melinda Gates Foundation, tried to use Wolbachia to shorten the lifespan of Aedes so that the virus would not have the 12 days necessary to develop. However, that approach seems unlikely to work, based on the mathematics of the spread of that type of Wolbachia.

Instead, the team found that Wolbachia itself suppresses certain viruses. The Gates Foundation is providing further funding to support release of infected mosquitoes in Australia, Vietnam and Thailand.

Related Stories

Recommended for you

The 'love hormone' may quiet tinnitus

September 23, 2016

(HealthDay)—People suffering from chronic ringing in the ears—called tinnitus—may find some relief by spraying the hormone oxytocin in their nose, a small initial study by Brazilian researchers suggests.

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Mosquitoes, Zika and biotech regulation

September 19, 2016

In a new Policy Forum article in Science, NC State professor Jennifer Kuzma argues that federal authorities are missing an opportunity to revise outdated regulatory processes not fit for modern innovations in biotechnology, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.